MICHELLE LANE: Open Payments
NPI 1639730690 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 29 payments from 15 companies in 2025. Trend: 2023 $1,621 · 2024 $191 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $80 |
| Novo Nordisk Inc | 4 | $73 |
| Astellas Pharma US Inc | 2 | $66 |
| Exact Sciences Corporation | 3 | $64 |
| ABBVIE INC. | 3 | $61 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Seqirus USA Inc | 2 | $52 |
| Insulet Corporation | 1 | $36 |
| Boston Scientific Corporation | 2 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
Products named: Korlym, Veozah, The Cologuard Plus Collection Kit, GARDASIL 9, Fluad, QULIPTA, Omnipod, WATCHMAN FLX.
Industry payments across NY — which companies pay providers there.
